A new study found that sodium-glucose cotransporter-2 (SGLT2) inhibitors might reduce gout risk in adults with type 2 diabetes. The study involved over 200,000...
A new study found that sodium-glucose cotransporter-2 (SGLT2) inhibitors might reduce gout risk in adults with type 2 diabetes. The study involved over 200,000...